Melatonin reverses depressive and anxiety like-behaviours induced by diabetes: involvement of oxidative stress, age, rage and S100B levels in the hippocampus and prefrontal cortex of rats

References

• Ahmed, N., 2005. Advanced glycation endproducts–role in pathology of diabetic complications. Diabetes research and clinical practice, 67 (1), 3–21.
   PubMed Web of Science ®Google Scholar
• An, H.M., et al., 2016. Beneficial effects of EGb761 and vitamin E on haloperidol-induced vacuous chewing movements in rats: Possible involvement of S100B mechanisms. Behavioural brain research, 297, 124–130.
   PubMed Web of Science ®Google Scholar
• Arolt, V., et al., 2003. S100B and response to treatment in major depression: a pilot study. European neuropsychopharmacology, 13 (4), 235–239.
   PubMed Web of Science ®Google Scholar
• Aykac, G., et al., 1985. The effects of chronic ethanol injection on hepatic lipid peroxide, glutathione, glutathione peroxidase and glutathione transferase in rats. Toxicology, 36, 71–76.
   PubMed Web of Science ®Google Scholar
• Bambolkar, S., and Sainani, G.S., 1995. Evaluation of oxidative stress in diabetics with or without vascular complications. Journal of the association of physicians of India, 43 (1), 10–12.
   PubMedGoogle Scholar
• Batlle, M., et al., 2015. Astroglia-microglia cross talk during neurodegeneration in the rat hippocampus. Biomed research international, 2015, 1.
   Web of Science ®Google Scholar
• Baydas, G., et al., 2003. Melatonin reduces glial reactivity in the hippocampus, cortex, and cerebellum of streptozotocin-induced diabetic rats. Free radical biology and medicine, 35 (7), 797–804.
   PubMed Web of Science ®Google Scholar
• Casini, A., et al., 1989. Lipid peroxidation and cellular damage in extrahepatic tissues of bromobenzene in toxicated mice. American journal of pathology, 123, 520–531.
   Google Scholar
• Castillo-Gómez, E., et al., 2015. Streptozotocin diabetic mice display depressive-like behavior and alterations in the structure, neurotransmission and plasticity of medial prefrontal cortex interneurons. Brain research bulletin, 116, 45–56.
   PubMed Web of Science ®Google Scholar
• Crupi, R., Mazzon, E., and Marıno, A., 2010. Melatonin treatment mimics the antidepressant action in chronic corticosterone treated mice. Journal of pineal research, 49, 123–129.
   PubMed Web of Science ®Google Scholar
• da Silva Dias, I.C., et al., 2016. Indoleamine-2,3-dioxygenase/kynurenine pathway as a potential pharmacological target to treat depression associated with diabetes. Molecular neurobiology, 53 (10), 6997–7009.
   PubMed Web of Science ®Google Scholar
• de Morais, H., et al., 2014. Increased oxidative stress in prefrontal cortex and hippocampus is related to depressive-like behavior in streptozotocin-diabetic rats. Behavioural brain research, 258, 52–64.
   PubMed Web of Science ®Google Scholar
• de Morais, H., et al., 2016. Anandamide reverses depressive-like behavior, neurochemical abnormalities and oxidative-stress parameters in streptozotocin-diabetic rats: Role of CB1 receptors. European neuropsychopharmacology, 26 (10), 1590–1600.
   PubMed Web of Science ®Google Scholar
• Franklin, T.C., et al., 2018. Persistent Increase in microglial rage contributes to chronic stress-ınduced priming of depressive-like behavior. Biological psychiatry, 83 (1), 50–60.
   PubMed Web of Science ®Google Scholar
• Goes, A.T.R., et al., 2018. Protective role of chrysin on 6-hydroxydopamine-induced neurodegeneration a mouse model of Parkinson's disease: involvement of neuroinflammation and neurotrophins. Chemico-biological interactions, 279, 111–120.
   PubMed Web of Science ®Google Scholar
• Gos, T., et al., 2013. S100B-immunopositive astrocytes and oligodendrocytes in the hippocampus are differentially afflicted in unipolar and bipolar depression: a postmortem study. Journal of psychiatric research, 47 (11), 1694–1699.
   PubMed Web of Science ®Google Scholar
• Gupta, D., Radhakrishnan, M., and Kurhe, Y., 2014. Ondansetron, a 5HT3 receptor antagonist reverses depression and anxiety-like behavior in streptozotocin-induced diabetic mice: possible implication of serotonergic system. European journal of pharmacology, 744, 59–66.
   PubMed Web of Science ®Google Scholar
• Karakaş, A., et al., 2011. The effects of the intraamygdalar melatonin injections on the anxiety like behavior and the spatial memory performance in male Wistar rats. Behavioural brain research, 222 (1), 141–150.
   PubMed Web of Science ®Google Scholar
• Lebed, Y.V., et al., 2008. Early reaction of astroglial cells in rat hippocampus to streptozotocin-induced diabetes. Neuroscience letters, 444 (2), 181–185.
   PubMed Web of Science ®Google Scholar
• Liu, J., et al., 2013. MT1 and MT2 melatonin receptors: a therapeutic perspective. Journal of affective disorders, 56, 361–383.
   Google Scholar
• Ma, Z., et al., 2017. Pathophysiology of depression: molecular regulation of melatonin homeostasis - current status. Cellular and molecular life sciences, 74 (21), 3989–3998.
   PubMed Web of Science ®Google Scholar
• Manev, R., Uz, T., and Manev, H., 2001. Fluoxetine increases the content of neurotrophic protein S100b in the rat hippocampus. European journal of pharmacology, 420 (2–3), R1–R2.
   PubMed Web of Science ®Google Scholar
• Nadeem, R.I., Ahmed, H.I., and El-Denshary, E.E., 2015. Effect of ımipramine, paroxetine, and lithium carbonate on neurobehavioral changes of streptozotocin in rats: ımpact on glycogen synthase kinase-3 and blood glucose level. Neurochemical research, 40 (9), 1810–1818.
   PubMed Web of Science ®Google Scholar
• Nardin, P., et al., 2016. Peripheral levels of ages and astrocyte alterations in the hippocampus of stz-diabetic rats. Neurochemical research, 41 (8), 2006–2016.
   PubMed Web of Science ®Google Scholar
• Ochoa-Sanchez, R., et al., 2012. Anxiolytic effects of the melatonin MT(2) receptor partial agonist UCM765: comparison with melatonin and diazepam. Progress in neuro-psychopharmacology and biological psychiatry, 39 (2), 318–325.
   PubMed Web of Science ®Google Scholar
• Origlia, N., et al., 2014. RAGE inhibition in microglia prevents ischemia-dependent synaptic dysfunction in an amyloid-enriched environment. Journal of neuroscience, 34 (26), 8749–8760.
   PubMed Web of Science ®Google Scholar
• Patel, S.S., et al., 2018. Antidepressant and anxiolytic like effects of Urtica dioica leaves in streptozotocin induced diabetic mice. Metabolic brain disease, 33 (4), 1281–1292.
   PubMed Web of Science ®Google Scholar
• Pereira, M.M., et al., 2018. The antioxidant gallic acid induces anxiolytic-, but not antidepressant-like effect, in streptozotocin-induced diabetes. Metabolic brain disease, 33 (5), 1573–1584.
   PubMed Web of Science ®Google Scholar
• Rahmani, G., et al., 2018. Garlic (Allium sativum) improves anxiety- and depressive-related behaviors and brain oxidative stress in diabetic rats. Archives of physiology and biochemistry, 31, 1–6.
   Google Scholar
• Ramírez-Rodríguez, G., et al., 2014. Melatonin synergizes with citalopram to induce antidepressant-like behavior and to promote hippocampal neurogenesis in adult mice. Journal of pineal research, 56 (4), 450–461.
   PubMed Web of Science ®Google Scholar
• Rebai, R., Jasmin, L., and Boudah, A., 2017. The antidepressant effect of melatonin and fluoxetine in diabetic rats is associated with a reduction of the oxidative stress in the prefrontal and hippocampal cortices. Brain research bulletin, 134, 142–150.
   PubMed Web of Science ®Google Scholar
• Rebolledo-Solleiro, D., and Fernández-Guasti, A., 2018. Influence of sex and estrous cycle on blood glucose levels, body weight gain, and depressive-like behavior in streptozotocin-induced diabetic rats. Metabolic brain disease, 33 (5), 1573–1584.
   PubMedGoogle Scholar
• Redivo, D.D., et al., 2016. Effect of omega-3 polyunsaturated fatty acid treatment over mechanical allodynia and depressive-like behavior associated with experimental diabetes. Behavioural brain research, 298 (Pt B), 57–64.
   PubMedGoogle Scholar
• Réus, G.Z., et al., 2016. Antioxidant treatment ameliorates experimental diabetes-induced depressive-like behaviour and reduces oxidative stress in brain and pancreas. Diabetes/metabolism research and reviews, 32 (3), 27.
   Web of Science ®Google Scholar
• Rong, H., et al., 2010. Chronic mild stress induces fluoxetine-reversible decreases in hippocampal and cerebrospinal fluid levels of the neurotrophic factor S100B and its specific receptor. International journal of molecular sciences, 11 (12), 5310–5322.
   PubMed Web of Science ®Google Scholar
• Safhi, M.M., et al., 2018. Thymoquinone and fluoxetine alleviate depression via attenuating oxidative damage and inflammatory markers in type-2 diabetic rats. Archives of physiology and biochemistry, 26, 1–6.
   Google Scholar
• Salahuddin, P., Rabbani, G., and Khan, R.H., 2014. The role of advanced glycation end products in various types of neurodegenerative disease: A therapeutic approach. Cellular & molecular biology letters, 19, 407–437.
   PubMed Web of Science ®Google Scholar
• Serrano, A., et al., 2017. The astrocytic S100B protein with ıts receptor RAGE is aberrantly expressed in SOD1G93A models, and ıts inhibition decreases the expression of proinflammatory genes. Mediators of inflammation, 2017, 1.
   Web of Science ®Google Scholar
• Stefanovic, B., et al., 2016. Melatonin mediated antidepressant-like effect in the hippocampus of chronic stress-induced depression rats: Regulating vesicular monoamine transporter 2 and monoamine oxidase A levels. European neuropsychopharmacology, 26 (10), 1629–1637.
   PubMed Web of Science ®Google Scholar
• Suchal, K., et al., 2017. Protective effect of mangiferin on myocardial ischemia-reperfusion injury in streptozotocin-induced diabetic rats: role of AGE-RAGE/MAPK pathways. Scientific reports, 7 (1), 42027.
   PubMedGoogle Scholar
• Tang, Z.J., et al., 2015. Antidepressant-like and anxiolytic-like effects of hydrogen sulfide in streptozotocin-induced diabetic rats through inhibition of hippocampal oxidative stress. Behavioural pharmacology, 26 (5), 427–435.
   PubMed Web of Science ®Google Scholar
• Taniguti, E.H., et al., 2018. Neuroprotective effect of melatonin against lipopolysaccharide-induced depressive-like behavior in mice. Physiology & behavior, 188, 270–275.
   PubMed Web of Science ®Google Scholar
• Tchekalarova, J., et al., 2018. Agomelatine treatment corrects symptoms of depression and anxiety by restoring the disrupted melatonin circadian rhythms of rats exposed to chronic constant light. Pharmacology biochemistry and behavior, 171, 1–9.
   PubMed Web of Science ®Google Scholar
• Wayhs, C.A., et al., 2013. Brain effect of insulin and clonazepam in diabetic rats under depressive-like behavior. Metabolic brain disease, 28 (4), 563–570.
   PubMed Web of Science ®Google Scholar
• Zhang, L., et al., 2017. Melatonin prevents sleep deprivation-associated anxiety-like behavior in rats: the role of oxidative stress and balance between GABAergic and glutamatergic transmission. American journal of translational research, 9 (5), 2231–2242.
   PubMed Web of Science ®Google Scholar